Komanr
Ronny
About

Currently holding Myovant: FDA approval/Pfizer deal for first oral ADT drug for advanced prostate cancer and BioCryst: FDA approval/funding for first oral drug for HAE attacks. Also working on oral Factor D inhibitor currently in Phase 1.

  • Fundamental, Long Term Investor, Novice
  • Member since December 4th 2019

1.2k

Ideas

0

Following

8

Followers

573

Liked

2

Watchlist

Real-Time